[Remote] Medical Director, Clinical Development at Abata Therapeutics

Remote

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, Clinical ResearchIndustries

Skills

Key technologies and capabilities for this role

Clinical Trial DesignProtocol DevelopmentData AnalysisGood Clinical Practice (GCP)Safety MonitoringRegulatory DocumentationMedical Expertise in Dermatology/Inflammatory Diseases

Questions & Answers

Common questions about this position

What is the work location and arrangement for this role?

The position is hybrid in Waltham, MA, requiring in-office presence 3 days per week, with remote work considered.

What is the salary for the Medical Director position?

This information is not specified in the job description.

What key skills or expertise are needed for this role?

Candidates need expertise in clinical trial design and oversight, medical knowledge of therapeutic areas and disease states, and ability to review clinical data for safety and efficacy while staying current with scientific literature and regulations.

What is the company culture like at Oruka Therapeutics?

Oruka is building a company culture focused on engagement, inclusion, and positivity.

What makes a strong candidate for this Medical Director role?

Strong candidates will have deep experience in clinical development, including trial protocol design, data review for safety and efficacy, and providing medical expertise in dermatologic or inflammatory diseases.

Abata Therapeutics

Develops therapies for autoimmune diseases

About Abata Therapeutics

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.

Cambridge, MassachusettsHeadquarters

2021Year Founded

$184.8MTotal Funding

EARLY_VCCompany Stage

BiotechnologyIndustries

11-50Employees

Risks

Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.

Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.

Rising clinical trial costs pose financial risks to Abata's pipeline progression.

Differentiation

Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.

Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.

Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.

Upsides

Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.

FDA's accelerated approval pathways may expedite Abata's clinical trials.

Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.

Land your dream remote job 3x faster with AI

Try Jobo Free